Studying the enhancement of programmed cell death by combined AG1024 and paclitaxel in a model of chronic myelogenous leukemia.

Cheng, Hao-Yuan

Studying the enhancement of programmed cell death by combined AG1024 and paclitaxel in a model of chronic myelogenous leukemia. [electronic resource] - Life sciences May 2014 - 118-26 p. digital

Publication Type: Journal Article

1879-0631

10.1016/j.lfs.2014.03.014 doi


Antineoplastic Agents, Phytogenic--administration & dosage
Apoptosis--drug effects
Drug Delivery Systems--methods
Drug Therapy, Combination
Humans
K562 Cells
Leukemia, Myelogenous, Chronic, BCR-ABL Positive--drug therapy
Paclitaxel--administration & dosage
Tyrphostins--administration & dosage
Up-Regulation--drug effects